Application 013055
- Type
- NDA
- Sponsor
- TELIGENT
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NORFLEX | ORPHENADRINE CITRATE | INJECTABLE;INJECTION | 30MG/ML | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N013055-001 | NORFLEX | ORPHENADRINE CITRATE | 30MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD, Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | N013055-001 | NORFLEX | 30MG/ML | INJECTABLE / INJECTION | RLD, Approved before 1982 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | N013055-001 | NORFLEX | 30MG/ML | INJECTABLE / INJECTION | RLD, Approved before 1982 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N013055-001 | NORFLEX | 30MG/ML | INJECTABLE / INJECTION | RLD, Approved before 1982 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N013055-001 | NORFLEX | 30MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD, Approved before 1982 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ORPHENADRINE CITRATE | ORPHENADRINE CITRATE | REMEDYREPACK INC. | 7905e80f-b60b-48e8-8e63-a3e50211bfe4 | 2026-08-10 | Warnings, Adverse reactions | ORPHENADRINE CITRATE |
| Orphenadrine Citrate | ORPHENADRINE CITRATE | Preferred Pharmaceuticals, Inc. | 8ca9438d-320f-4499-aee7-6b8ca7cccc65 | 2026-08-07 | Warnings, Adverse reactions | ORPHENADRINE CITRATE |
| Orphenadrine Citrate | ORPHENADRINE CITRATE | St. Mary's Medical Park Pharmacy | 59000b66-166e-75d2-e053-2a91aa0af3c0 | 2026-06-26 | Warnings, Adverse reactions | ORPHENADRINE CITRATE |
| ORPHENADRINE CITRATE | ORPHENADRINE CITRATE | Bryant Ranch Prepack | 1b4e379e-8051-421f-a0f4-ad9e6fb9476a | 2026-02-26 | Warnings, Adverse reactions | ORPHENADRINE CITRATE |
| Orphenadrine Citrate | ORPHENADRINE CITRATE | A-S Medication Solutions | 80ef7fb4-7c50-4d25-915e-f9d4a2ccd199 | 2026-01-20 | Warnings, Adverse reactions | ORPHENADRINE CITRATE |
| ORPHENADRINE CITRATE | ORPHENADRINE CITRATE | PD-Rx Pharmaceuticals, Inc. | 87d78229-f022-4b42-a03c-4e6a985c714f | 2026-01-07 | Warnings, Adverse reactions | ORPHENADRINE CITRATE |
| ORPHENADRINE CITRATE | ORPHENADRINE CITRATE | Northwind Health Company, LLC | 106be130-b4f8-5ca1-e063-6294a90a1590 | 2026-01-01 | Warnings, Adverse reactions | ORPHENADRINE CITRATE |
| ORPHENADRINE CITRATE | ORPHENADRINE CITRATE | Lupin Pharmaceuticals, Inc. | 7b76c8a7-dd0c-481c-8299-26dfd38ce066 | 2025-09-10 | Warnings, Adverse reactions | ORPHENADRINE CITRATE |
| Orphenadrine Citrate ER | ORPHENADRINE CITRATE | Advanced Rx Pharmacy of Tennessee, LLC | b5a6846a-ebb3-1fdd-e053-2a95a90a4130 | 2024-12-31 | Warnings, Adverse reactions | ORPHENADRINE CITRATE |
| ORPHENADRINE CITRATE | ORPHENADRINE CITRATE | Advanced Rx Pharmacy of Tennessee, LLC | fc63d413-39bd-409d-e053-6294a90a1463 | 2024-12-31 | Warnings, Adverse reactions | ORPHENADRINE CITRATE |
| Orphenadrine Citrate | ORPHENADRINE CITRATE | Lake Erie Medical DBA Quality Care Products LLC | 233915f1-7d58-4b4c-a2bb-e73179d61d07 | 2024-12-16 | Warnings, Adverse reactions | ORPHENADRINE CITRATE |
| Orphenadrine Citrate | ORPHENADRINE CITRATE | Bryant Ranch Prepack | 8408d24e-3948-548d-bb12-b1edf0c05e12 | 2024-08-27 | Warnings, Adverse reactions | ORPHENADRINE CITRATE |
| Orphenadrine Citrate | ORPHENADRINE CITRATE | NuCare Pharmaceuticals, Inc. | 3eb1b1cc-ed7a-6f0f-e054-00144ff88e88 | 2024-08-13 | Warnings, Adverse reactions | ORPHENADRINE CITRATE |
| Orphenadrine citrate | ORPHENADRINE CITRATE | Hikma Pharmaceuticals USA Inc. | ed406e8a-ec00-4711-ae2b-3c5af4f15438 | 2024-08-08 | Warnings, Adverse reactions | ORPHENADRINE CITRATE |
| Orphenadrine Citrate | ORPHENADRINE CITRATE | RedPharm Drug | 1cff761d-e594-a9e6-e063-6394a90a1fd5 | 2024-07-11 | Warnings, Adverse reactions | ORPHENADRINE CITRATE |
| Orphenadrine Citrate | ORPHENADRINE CITRATE | Sandoz Inc | 239018ff-cec6-46de-ae9d-26c9ec034a32 | 2024-03-22 | Warnings, Adverse reactions | ORPHENADRINE CITRATE |
| Orphenadrine Citrate | ORPHENADRINE CITRATE | Proficient Rx LP | cf620257-7497-44c1-9853-87f96d262fbd | 2023-12-01 | Warnings, Adverse reactions | ORPHENADRINE CITRATE |
| Orphenadrine Citrate | ORPHENADRINE CITRATE | Sagent Pharmaceuticals | c8d8596a-b81f-4b83-a2f3-a55922ca4a82 | 2023-11-14 | Warnings, Adverse reactions | ORPHENADRINE CITRATE |
| Orphenadrine Citrate | ORPHENADRINE CITRATE | Proficient Rx LP | 37e6a157-5d0d-4887-9a26-ed5521fb08e6 | 2019-11-01 | Warnings, Adverse reactions | ORPHENADRINE CITRATE |
| Orphenadrine Citrate | ORPHENADRINE CITRATE | Actavis Pharma, Inc. | aec8ad3a-f717-4e74-b7b9-19debdaad79a | 2016-07-20 | Warnings, Adverse reactions | ORPHENADRINE CITRATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.